 BOSTON, Oct. 26, 2021 GLOBE NEWSWIRE -- Galecto, Inc. NASDAQ: GLTO, a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that Galectos management team will be presenting virtually at the Credit Suisse Healthcare Conference and in-person at the Jefferies London Healthcare Conference. Galectos management team will be available for 1x1 meetings at both of these conferences. Details for the presentations are below: 